INTRODUCTION {#S1}
============

Abasic sites, also known as apurinic or apyrimidinic sites (AP sites), occur between 10,000 and 50,000 times per cell per day. Base loss generating an abasic site can occur spontaneously or in response to DNA damage induced by endogenous and exogenous sources, including both oxidative and alkylation base damage. Abasic site repair in double-strand DNA (dsDNA) is performed primarily by base-excision repair (BER) using AP endonucleases ([@R3]; [@R31]). During DNA replication, abasic sites that escape BER will stall the replicative polymerases, generating a single-strand DNA (ssDNA) abasic site. Replication-associated ssDNA abasic lesions can also form directly on the lagging-strand template because of cytosine deamination and removal by uracil N-glycosylase (UNG). These lesions have substantial mutagenic potential because they are often bypassed by translesion synthesis (TLS) polymerases. In addition, they are prone to undergoing β-elimination reactions or cleavage by endonucleases that result in DNA breaks ([@R30]; [@R31]). Thus, the action of BER enzymes, such as AP endonuclease-1 and −2 (APEX1 and APEX2), would be deleterious in the context of ssDNA.

5-Hydroxymethylcytosine (5hmC) binding, ES-cell-specific (HMCES), travels with replication forks ([@R20]), binds proliferating cell nuclear antigen (PCNA) and ssDNA ([@R20]), and uses an N-terminal cysteine to form a DNA-protein crosslink (DPC) via a thiazolidine linkage with ssDNA abasic sites ([@R11]; [@R32]; [@R33]). This linkage can be made at an abasic site positioned at a junction of ssDNA and dsDNA with a free 3′ terminus, similar to what would be formed when a polymerase stalls at an abasic site in template DNA ([@R32]). HMCES-deficient cells are hypersensitive to ultraviolet radiation (UV), ionizing radiation (IR), the alkylating agent methyl methanesulfonate (MMS), and the oxidizing agent potassium bromate ([@R20]). These DNA-damaging agents result in multiple types of lesions, but all can generate abasic sites. Furthermore, a HMCES DPC forms in cells treated with these agents. Thus, we hypothesized that HMCES is a shield for ssDNA abasic sites to prevent DNA cleavage and perhaps shunt ssDNA abasic site processing through a less mutagenic pathway ([@R20]). Other studies suggest that HMCES is an epigenetic reader of 5-hydroxymethylcytosine, a cysteine protease, and an alternative non-homologous end-joining repair factor ([@R1]; [@R18]; [@R25]; [@R27]). How these functions relate to an activity in abasic site processing is unclear.

Because IR, UV, MMS, and potassium bromate only indirectly induce abasic sites and primarily generate other types of lesions that cause mutations and cell lethality, we sought a more-specific approach to testing the hypothesis that HMCES initiates an ssDNA abasic-site-repair mechanism. In this study, we used the cytidine deaminase APOBEC3A to test that idea. APOBEC proteins preferentially deaminate cytosines in ssDNA ([@R13]). Thus, when aberrantly expressed in cancers, they target the lagging DNA template strand during replication and generate mutational signatures caused by misincorporation across from uracils and abasic sites ([@R4]; [@R12]; [@R15]; [@R21]; [@R24]).

We find that HMCES-deficient cells are hypersensitive to nuclear APOBEC3A localization. HMCES prevents the processing of APOBEC3A-induced lesions into DSBs, supporting the idea that HMCES shields ssDNA abasic sites from aberrant processing to maintain genome integrity. In addition, we find that abasic sites induced by APOBEC3A slow replication elongation. The APOBEC3A-induced slowing is exacerbated by HMCES deficiency and abrogated when both TLS polymerization and HMCES are in-activated. Thus, HMCES facilitates fork progression that otherwise is slowed by TLS polymerase engagement at abasic sites.

RESULTS {#S2}
=======

HMCES-Deficient Cells Are Hypersensitive to ssDNA Abasic Site Induction {#S3}
-----------------------------------------------------------------------

To test the hypothesis that HMCES responds directly to ssDNA abasic sites, we generated cell lines (hTERT-RPE-1 and HCT116) stably expressing GFP-tagged APOBEC3A fused to the mutant estrogen receptor (GFP-APOBEC3A-ERT2; [Figure S1A](#SD1){ref-type="supplementary-material"}). This system allows for rapid translocation of APOBEC3A into the nucleus upon treatment with 4-hydroxytamoxifen (4-OHT) ([Figure S1B](#SD1){ref-type="supplementary-material"}). In contrast to previous studies that used 24--48 h of transcriptional induction to achieve APOBEC3A and APOBEC3B overexpression ([@R4]; [@R19]), the localization system allows us to examine the consequences of nuclear APOBEC3A activity in minutes to hours. Once in the nucleus, APOBEC3A catalyzes the deamination of cytosine to uracil in ssDNA. The deaminated base is then removed by UNG, generating an abasic site ([@R28]).

In both hTERT-RPE-1 epithelial and HCT116 colorectal cancer cell lines, 4-OHT-induced nuclear localization of APOBEC3A led to a modest decrease in viability that was exacerbated by inactivating HMCES ([Figures 1A](#F1){ref-type="fig"}--[1C](#F1){ref-type="fig"}, [S1C](#SD1){ref-type="supplementary-material"}, and [S1D](#SD1){ref-type="supplementary-material"}). HMCES depletion, even in the absence of 4-OHT, also reduced the viability of the hTERT-RPE-1-APOBEC3A cells. This may indicate a greater dependency on HMCES in those cells or reflect some leakiness of the 4-OHT-regulated APOBEC3A fusion protein. Thus, HMCES promotes cell survival in response to nuclear APOBEC3A.

APOBEC3A Induces Re-localization of HMCES to Chromatin {#S4}
------------------------------------------------------

HMCES-deficient cells are hypersensitive to DNA-damaging agents that promote HMCES localization to chromatin and DPC formation ([@R20]). Because HMCES-deficient cells are hypersensitive to nuclear APOBEC3A, we wanted to determine whether APOBEC3A also produced a change in HMCES localization. Standard immunofluorescence imaging does not yield strong HMCES staining in cells extracted with detergent to remove soluble HMCES, whether or not they are treated with DNA-damaging agents. Therefore, we applied a high-content microscopy methodology based on the proximity ligation assay (PLA) to detect insoluble, chromatin-bound HMCES and first validated this method with UV radiation. Cells were irradiated, allowed to recover for 4 h, and soluble HMCES protein was removed by detergent pre-extraction before fixation. The amount of insoluble HMCES remaining was then quantified by PLA ([Figure S2A](#SD1){ref-type="supplementary-material"}). Consistent with our previous chromatin fractionation and rapid approach to DNA adduct recovery (RADAR) data ([@R20]), this assay measures elevated levels of insoluble HMCES after exposure to UV radiation specifically in S-phase (EdU-positive) cells ([Figures S2B](#SD1){ref-type="supplementary-material"} and [S2C](#SD1){ref-type="supplementary-material"}). The HMCES PLA signal can be further increased upon incubation with the proteasome inhibitor MG132 ([Figures S2B](#SD1){ref-type="supplementary-material"} and [S2D](#SD1){ref-type="supplementary-material"}), which was shown to increase HMCES-DPC levels after UV radiation ([@R20]). As expected, the HMCES PLA signal is not observed in HMCES knockout cells (HMCESD) or cells processed without a primary antibody ([Figures S2B](#SD1){ref-type="supplementary-material"} and [S2D](#SD1){ref-type="supplementary-material"}).

We applied this assay to hTERT-RPE-1 cells with and without stable expression of APOBEC3A. The HMCES PLA signal is slightly elevated in S-phase cells expressing APOBEC3A compared with the parental cell line before the addition of 4-OHT and is further increased after 4-OHT treatment to induce nuclear APOBEC3A accumulation ([Figures 1D](#F1){ref-type="fig"} and [S2E](#SD1){ref-type="supplementary-material"}). The elevation of signal before the addition of 4-OHT may again indicate some leakiness of the APOBEC3A fusion protein causing a low level of nuclear APOBEC3A localization. Unlike the S-phase-specific HMCES PLA signal observed after UV radiation, APOBEC3A nuclear localization also modestly increased the HMCES PLA signal in EdU-negative cells ([Figure 1E](#F1){ref-type="fig"}). APOBEC3A can deaminate cytosines in ssDNA formed at transcription bubbles, possibly providing a source for the HMCES PLA signal in non-replicating cells ([@R15]). These results suggest that HMCES is recruited to chromatin in response to APOBEC3A nuclear localization and reveal that HMCES can function in contexts other than DNA replication.

HMCES Protects Abasic Sites from Generating DSBs {#S5}
------------------------------------------------

One rationale for the HMCES pathway is that it may shield ssDNA abasic sites from inappropriate nucleolytic processing that would generate DSBs. Previous biochemical experiments demonstrated that the HMCES DPC protects ssDNA abasic sites from APE1-dependent cleavage ([@R20]; [@R32]). To test whether this is also the case in cells, we measured DSB formation using neutral comet assays. 1 h of 4-OHT treatment to induce APOBEC3A nuclear localization generated a modest increase in DSB formation in control cells, which was significantly elevated when HMCES was inactivated ([Figure 2A](#F2){ref-type="fig"}). The 4-OHT-dependent breaks could be further increased by exogenously treating the nuclei in the agarose plugs with AP endonuclease 1 (APE1) before electrophoresis ([Figure 2B](#F2){ref-type="fig"}). The increase in DSBs after APE1 treatment is much larger in HMCES-deficient cells, suggesting that HMCES can prevent APE1 processing and DSB formation at abasic lesions.

If HMCES protects abasic sites from BER-dependent processing, we reasoned that inactivating AP endonucleases in human cells lacking HMCES may reduce the frequency of DSBs. To test that hypothesis, we silenced the two major AP-endonucleases, APEX1 and APEX2, in HMCESD U2OS cells that were previously reported to contain elevated levels of DSBs compared with parental U2OS ([@R20]). Inactivating APEX1 had little effect, whereas inactivating APEX2 caused a modest increase in breaks. Contrary to reducing DSB formation, inactivating both endonucleases simultaneously produced a significant increase in DSBs in HMCES-deficient cells ([Figure S3](#SD1){ref-type="supplementary-material"}). One likely explanation is that inactivating AP endonucleases greatly increases the frequency of abasic sites in dsDNA ([@R7]; [@R20]; [@R26]). These persistent dsDNA abasic sites would be converted to ssDNA abasic sites during replication or transcription and could undergo b-elimination or processing by endonucleases other than APEX1 and APEX2 when HMCES is not present to protect them.

APOBEC3A-Induced ssDNA Abasic Sites Slow Replication Elongation {#S6}
---------------------------------------------------------------

Because APOBEC enzymes deaminate cytosines on the lagging strand ssDNA template ([@R15]; [@R24]) and HMCES localizes to DNA in response to APOBEC3A nuclear localization, we examined whether nuclear APOBEC3A expression alters replication kinetics. Surprisingly, APOBEC3A nuclear localization is sufficient to significantly slow replication elongation ([Figure 3A](#F3){ref-type="fig"}). This slowing was observed in three independent clones of HCT116 cells expressing APOBEC3A and is not an off-target effect of 4-OHT treatment since replication kinetics were unchanged in parental HCT116 cells ([Figure 3A](#F3){ref-type="fig"}). Treatment with 4-OHT for as little as 30 min was sufficient to slow elongation ([Figure 3B](#F3){ref-type="fig"}). Because DNA combing monitors both lagging and leading strand synthesis, both must be slowed by nuclear APOBEC3A expression.

APOBEC3A relies on UNG to convert the deaminated cytosines (uracils) to abasic sites. To confirm that the replication fork slowing is due to abasic sites and not simply uracil formation, we used a uracil-DNA glycosylase inhibitor (UGI) ([@R2]). The UGI was expressed in APOBEC3A cells by lentiviral infection, and *in vitro* assays with cell extracts confirmed complete UNG inactivation within 16 h of infection ([Figure 3C](#F3){ref-type="fig"}). UNG inhibition fully rescued the fork-elongation defect associated with nuclear APOBEC3A in both HCT116 and hTERT-RPE-1 cells ([Figures 3B](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}). Thus, abasic sites, not uracils, are responsible for slowing replication elongation.

HMCES and TLS Control Replication Elongation in Response to Abasic Sites {#S7}
------------------------------------------------------------------------

To determine how HMCES influences APOBEC3A-induced replication-elongation slowing, we repeated the DNA combing experiments in cells lacking HMCES. HMCES inactivation alone has minor effects on replication elongation in HCT116 or hTERTRPE-1 cells ([Figure 4A](#F4){ref-type="fig"}). However, HMCES deficiency in combination with nuclear APOBEC3A localization significantly slowed replication elongation in both HCT116 and hTERT-RPE-1 cells relative to HMCES-proficient cells treated with 4-OHT ([Figure 4A](#F4){ref-type="fig"}). This replication-elongation defect was rescued by UNG inhibition, indicating abasic sites are again the relevant DNA lesion that slows fork elongation ([Figure 4B](#F4){ref-type="fig"}). Thus, the HMCES pathway helps to maintain elongation rates in response to increased levels of ssDNA abasic sites.

iPOND (isolation of proteins on nascent DNA) stable isotope labeling with amino acids in cell culture (SILAC)-mass spectrometry analysis, comparing HMCES-proficient and HMCESΔ cells, indicated that the TLS proteins REV1 (a TLS scaffold) and REV3 (the catalytic subunit of Polζ) are enriched at replication forks when HMCES is inactivated ([@R20]). Therefore, we considered whether the elongation kinetics in HMCES-deficient cells expressing nuclear APOBEC3A could be influenced by use of Polζ.

JH-RE-06 is a selective inhibitor of the REV1 and REV7 interaction, thereby inhibiting Polζ ([@R34]). Polζ inhibition by JH-RE-06 does not change elongation rates by itself and does not exacerbate or rescue the slow elongation kinetics caused by APOBEC3A-mediated abasic sites in HMCES-proficient cells ([Figure 4C](#F4){ref-type="fig"}). However, JH-RE-06 treatment largely restores normal elongation rates when HMCES is inactivated ([Figure 4C](#F4){ref-type="fig"}).

Polζ can insert nucleotides across from an abasic site, but its most characterized function is to extend 3′ termini after other TLS polymerases insert a base across from the lesion ([@R8]; [@R29]). *In vitro* studies indicate TLS polymerase kappa (Polκ) can insert a base across from a template abasic site in some sequence contexts, although other studies indicate this incorporation is the least efficient of all TLS polymerases ([@R5]; [@R36]). Furthermore, Polκ was shown to cause fork slowing in other contexts ([@R17]) Therefore, we tested whether Polκ could be involved in slowing the elongation in HMCES-deficient cells. Indeed, small interfering RNA (siRNA) depletion of Polκ suppresses the decreased elongation rate caused by HMCES inactivation in nuclear APOBEC3A-expressing cells, although it does not fully restore the elongation kinetics to normal ([Figure 4D](#F4){ref-type="fig"}). These results suggest that, in the absence of HMCES, TLS polymerases Polζ and Polκ slow elongation by engagement of the abasic-site-containing DNA template.

DISCUSSION {#S8}
==========

HMCES-deficient cells are hypersensitive to multiple DNA-damaging agents that can generate a common lesion, an abasic site ([@R20]). However, whether HMCES actually responds to abasic sites in cells was unclear because these agents generate many types of DNA lesions, and other studies reported various functions for HMCES, unrelated to abasic sites ([@R1]; [@R18]; [@R25]; [@R27]). We now find that HMCES does indeed respond to abasic sites and shields them from being processed into DSBs. HMCES helps to maintain replication fork speed by preventing TLS-induced replication fork slowing in response to ssDNA abasic site damage. Inactivating both HMCES and TLS returns elongation kinetics to normal. However, this improvement in fork speeds comes at the expense of increased DSBs and decreased cell viability since inactivating HMCES and TLS polymerases generates synthetic lethality ([@R20]).

Because APOBEC3A preferentially targets the lagging template strand and the DNA-combing methodology monitors synthesis on both strands, our fork-slowing data suggest that lagging-strand abasic sites may not only impair lagging-strand synthesis but also slow leading strand polymerization. This observation is unexpected because lagging strand lesions are generally thought to be bypassed easily by re-priming because of the discontinuous nature of lagging-strand synthesis ([@R6]; [@R14]; [@R35]). There may be coupling of lagging and leading strand synthesis such that lagging-strand blocks also slow leading strand polymerization. Alternatively, nuclear APOBEC3A expression could induce abasic sites in both the leading and lagging strand templates. HMCES is recruited to chromatin in response to APOBEC3A expression even in cells not incorporating EdU, reflecting the ability of APOBECs to act in contexts other than replication. If these lesions escape excision repair, they could be present in the leading strand template to slow leading strand synthesis.

HMCES inactivation exacerbates the fork-elongation defect caused by APOBEC3A-induced abasic sites, but that slowing can be rescued by inactivating Polζ or Polκ. These results suggest that HMCES helps to maintain fork movement by preventing engagement of these TLS polymerases at forks stalled by abasic sites. These results are consistent with the observation that HMCES-deficient cells have elevated levels of Polζ at replication forks and increased Polζ-dependent mutation frequencies ([@R20]). Polκ has been reported to inefficiently bypass abasic sites, and its activity slows replication ([@R5]; [@R17]; [@R36]). The inefficiency of Polκ abasic site bypass may directly contribute to slower replication elongation. Whether this is also true for other TLS polymerases will be important to test because many polymerases can bypass abasic sites ([@R31]). The slowing caused by Polζ, which largely acts in the extension step of TLS after the action of another polymerase, suggests a more general effect of TLS pathways on fork movement and also indicates that TLS polymerases likely engage the replication fork directly and not only at post-replicative gaps. One possibility is that TLS engagement prevents faster pathways like re-priming from acting.

Removal of the uridine after cytidine deamination to generate an abasic site can reduce mutagenesis because uracil always leads to a C to T mutation, whereas conversion to an abasic site preserves the possibility that error-free repair mechanisms can operate ([@R16]). However, abasic sites increase the likelihood of strand cleavage. Thus, HMCES binding the abasic site may preserve genome stability by preventing DSB formation and providing time for error-free repair. The mechanism that generates the DSBs in the absence of HMCES is not clear. Although biochemical studies indicate that HMCES blocks the action of AP endonucleases and we find that AP endonucleases can cleave the abasic sites when HMCES is not present, the two major AP endonucleases (APEX1 or APEX2) are not required to generate the DSBs in cells. In fact, inactivating those enzymes actually generates more abasic sites and more DSBs. Many other enzymes are capable of strand cleavage at abasic sites or can process stalled forks into DSBs. Nucleophiles also promote β-elimination reactions at abasic sites yielding strand cleavage. Thus, there may be multiple sources of the DSBs in HMCES-deficient cells.

In addition to DSBs, abasic sites can generate other forms of DNA damage including interstrand and DNA protein crosslinks. Given the frequency of abasic sites and their potential to generate genome instability, organisms have many alternative mechanisms to deal with this lesion in different DNA contexts. In addition to BER, HMCES, and TLS, the Shu complex in yeast can shield ssDNA abasic sites from digestion by AP endonucleases ([@R22]). Further studies will be needed to understand how pathway choice is regulated and the mechanism by which the HMCES-bound abasic site is ultimately resolved.

In conclusion, HMCES responds to APOBEC3A-induced abasic sites, maintains genome stability, and facilitates replication elongation that would otherwise be slowed by the engagement of TLS polymerases. Because deregulated APOBEC activity is a source of mutagenesis in multiple cancer types, future studies should examine the balance among HMCES, TLS, and endonuclease processing to understand their importance in this process of tumorigenesis.

STAR★METHODS {#S9}
============

RESOURCE AVAILABILITY {#S11}
---------------------

### Lead Contact {#S12}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David Cortez (<david.cortez@vanderbilt.edu>).

### Materials Availability {#S13}

Plasmids and cell lines generated in this study are available upon request from the lead contact.

### Data and Code Availability {#S14}

The published article includes all datasets generated or analyzed during this study.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S15}
--------------------------------------

### Cell lines {#S16}

HCT116 GFP-APOBEC3A-ERT2 cells were cultured in 7.5% McCoy's 5A supplemented with 7.5% Charcoal-Stripped FBS. hTERT-RPE-1 GFP-APOBEC3A-ERT2 were cultured in DMEM:F12 supplemented with Charcoal-Stripped FBS. U2OS were cultured in DMEM supplemented with 7.5% FBS. Cells were culture at 37C and 5% CO~2~ with humidity. All cell lines were regularly tested for mycoplasma and verified using short tandem repeat profiling. U2OS and hTERT-RPE-1 are female. HCT116 are male.

METHOD DETAILS {#S17}
--------------

### Generation of APOBEC3A stable cell lines {#S18}

HCT116 cells were transfected with pACGFP-APOBEC3A-ERT2, selected with 500 mg/ml G418, and plated for individual clones using GFP fluorescent activated cell sorting (FACS). HCT116 and hTERT-RPE-1 were transfected with PiggyBac (PB510 Puro or PB533 Neo)-GFP-APOBEC3A-ERT2 along with the Super PiggyBac Transposase expression vector (PB210PA), selected with 2 μg/ml puromycin or 1 mg/ml G418, and populations of GFP-positive cells were subsequently sorted using FACS. GFP-APOBEC3A-ERT2 expression was verified by immunoblot.

### Cell Transfections {#S19}

Plasmid transfections were performed with Fugene 6 (pAcGFP-APOBEC3A-ERT2) or PureFection Transfection Reagent (System Biosciences, PiggyBac-GFP-APOBEC3A-ERT2, PB510B-1). siRNA transfections were performed with Dharmafect-1 (Dharmacon).

### Plasmids {#S20}

The APOBEC3A cDNA was obtained from the Thermo Scientific Open Biosystems Human ORFeome collection (Cat\# OHS5894-9916829). The pACGFP-ERT2 vector was provided by Dr. Neils Mailand ([@R10]). PiggyBac transposon vectors were purchased from Systems Biosciences. pUGI-NLS UDG Inhibitor (UGI) was purchased from Addgene (Cat\#101091).

### siRNAs and Antibodies {#S21}

siRNAs were obtained from QIAGEN or Dharmacon as specified. AllStars Negative Control siRNA QIAGEN cat\#1027281. siHMCES-1 Cat\#D-020333--01, siHMCES-2 Cat\#J-020333--19. siPolymerase Kappa Cat\#D-021038--01, Cat\#D-021038--02, Cat\#D-021038--03, Cat\#D-021038--04. siAPEX1 Cat\#D-010237--01, Cat\#D-010237--02, Cat\#D-010237--03, Cat\#D-010237--05. siAPEX2 Cat\#D-013730--01, Cat\#D-013730--02, Cat\#D-013730--03, Cat\#D-013730--04. Antibodies: APOBEC3A (Sigma, Cat\#SAB4500753), HMCES (Sigma, Cat\#HPA044968), GFP (Abcam, Cat\#ab290), BrdU (Abcam, Cat\#ab6326), BrdU (BD Cat\#347580), Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Life Technologies, Cat\#A32723), Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 594 (Life Technologies, Cat\#A11007).

### Live Cell Fluorescence Assays {#S22}

Live cells were plated in a 96-well glass bottom dish. Following treatment with 10 μM 4-hydroxytamoxifen (4-OHT), cells were incubated with 1 μg/ml Hoechst 33342 in PBS for 10 min, rinsed with PBS and imaged using an ImageXpress (Molecular Devices).

### Viability Assays {#S23}

Cells were plated for the long-term clonogenic survival assays 48 h after siRNA transfection, and were subsequently treated with 10 μM 4-OHT for 24 h (Tocris, Cat\#3412/10). 4-OHT was washed out and colonies were allowed to grow for approximately two weeks prior to scoring by methylene blue staining (48% methanol, 2% methylene blue, 50% water). All clonogenic survival assays were completed in triplicate with three experimental replicates per biological replicate.

### Western Blot {#S24}

Whole-cell lysates were extracted using Igepal lysis buffer (50 mM Tris \[pH 7.4\], 150 mM NaCl, 1% Igepal CA-630, 1 mM EDTA, pH 8.5) enriched with sodium fluoride (1 mM), sodium vanadate (1 mM), protease inhibitor cocktail (Roche), phenylmethylsulfonyl fluoride (PMSF, 1 mM), 25 units of Pierce Universal Nuclease, and 1 mM MgCl~2~. Proteins were analyzed by SDS-PAGE and immunoblotting.

### Proximity ligation assay {#S25}

Cells were plated in a 96-well glass bottom dish. Following the indicated treatments, cells were pre-extracted in ice-cold pre-extraction buffer (20 mM HEPES, 50 mM NaCl, 3 mM MgCl~2~, 300 mM sucrose, 0.5% Triton X-100), and subsequently fixed with 3% paraformaldehyde, 2% sucrose. Cells were then permeabilized (20 mM HEPES, 50 mM NaCl, 3 mM MgCl~2~, 300 mM sucrose, 0.5% Triton X-100), and blocked (1 mg/ml BSA, 5% Goat Serum, 0.1% Triton X-100, 1mM EDTA). EdU incorporation was detected by a click reaction using Alexa Fluor 488 azide (Invitrogen). The proximity ligation assay was then performed as per manufacturer's instructions (Sigma) using a HMCES polyclonal antibody (Sigma HPA044968). Images were acquired using the 20X objective on an ImageXpress (Molecular Devices) and analyzed with MetaXpress software.

### UNG cellular activity assay {#S26}

The UDG inhibitor (UGI; Addgene, Cat\#101091) was cloned into the lentiviral plasmid pLX301 and co-transfected with pPAX2 and pCMV-VSV-G into 293(F)T packaging cells. Supernatants were collected 46 h after transfection, filtered, diluted 1:5 in growth media, and supplemented with 4 μg/ml polybrene. Target cells were infected once, harvested 16 h post-infection, and lysed in 50 mM Tris-Cl pH 7.4, 1% Igepal, 0.1% sodium deoxycholate, 10% glycerol, 150 mM NaCl, 1 mM DTT, 20 μg/ml RNaseA with an EDTA-free protease inhibitor cocktail tablet (Roche). To test for inhibition, 16 μl each lysate (or buffer) was incubated with 100 nM of a 42 nucleotide ssDNA oligonucleotide with a single deoxyuridine and a 5′ fluorescein tag (5′ (6-FAM)-CTA TGA TGA CTC TTC TGG TCU GGA TGG TAG TTA AGT GTT GAG 3′) at 37°C and 8 μl was removed at 15 min and 30 min. As a control, 5 units of purified UDG from *E. coli* (New England Biolabs) was added to one reaction. The DNA was then heated at 95°C for 10 min in the presence of 0.2 M NaOH to cleave abasic sites. Samples were mixed with an equal volume of formamide/EDTA loading buffer, resolved on a 10% TBE-Urea gel, and scanned using a Typhoon imager (GE Healthcare).

### DNA molecular combing {#S27}

Cell were labeled with 20 μM CldU (Sigma, C6891) followed by 100 μM IdU (Sigma, l7125), for the time indicated, with or without 10 μM 4-OHT (Tocris, 3412/10), JH-RE-06 (Vanderbilt Chemical Synthesis Core), or following 16 h infection with UGI. Approximately 400,000 cells were embedded in agarose plugs and the assay was performed as per Genomic Vision's manufacturer instructions. The DNA was stained with antibodies that recognize IdU and CldU (Abcam Cat\#ab6326, BD Cat\#347580) for 1 h, washed in PBS, and probed with secondary antibodies for 45 min. Images were obtained using a 40X oil objective (Nikon Eclipse Ti). Analysis of fiber lengths performed using Nikon Elements software.

### Neutral Comet Assay {#S28}

Trevigen CometAssay ESII system was utilized to detect DNA double-strand breaks, and the assay was performed as per manufacturer's instructions (Trevigen). Neutral comet assay with exogenous APE-I digestion was performed as per manufacturer's instructions, however, agarose plugs were treated with 10 units per ml APE-I (NEB, M0282S) at 37°C prior to electrophoresis. Tail moments were scored using the open source Fiji and OpenComet software ([@R9]; [@R23]).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S29}
---------------------------------------

Statistical analyses were completed using Prism 8 (GraphPad). An ANOVA test was used when comparing more than two groups followed by a Holm-Sidak or Dunn's post-test. No statistical methods or criteria were used to estimate sample size or to include/exclude samples. Multiple siRNAs, multiple clones, multiple approaches, and multiple cell lines were analyzed to confirm results were not caused by off-target effects or clonal variations. Unless otherwise stated, all experiments were performed at least twice and representative experiments are shown.
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![HMCES-Deficient Cells Are Hypersensitive to Nuclear APOBEC3A Expression, Which Promotes HMCES Localization to the Chromatin\
(A) Representative images of a colony-viability assay in hTERT-RPE-1 GFP-APOBEC3A-ERT2 cells transfected with non-targeting control (NT) or HMCES (H-1 and H-2) siRNAs and treated with 4-OHT for 24 h.\
(B and C) Quantitation of clonogenic survival assays for RPE A3A (B) and HCT116 A3A (C). Means and SD of 3 experiments. p values were derived from an ANOVA with Holm-Sidak post-test.\
(D and E) Quantitation of the insoluble HMCES PLA signal after 4-OHT treatment in EdU-positive (D) and EdU-negative (E) hTERT-RPE-1 cells, with and without stable expression of GFP-APOBEC3A-ERT2. (−1°, no primary HMCES antibody). Each data point represents the HMCES-PLA-integrated nuclear intensity in one cell. Bars represent the median, and p values were derived from an ANOVA with Dunn's multiple comparisons post-test. See also [Figures S1](#SD1){ref-type="supplementary-material"} and [S2](#SD1){ref-type="supplementary-material"}.](nihms-1600577-f0002){#F1}

![HMCES Protects Cells from APOBEC3A-Induced DSBs\
(A)Cells were transfected with HMCESsiRNAs (H-1, H-2) or a non-targetingsiRNA (NT) and treated with 4-OHT for 1 h as indicated prior to neutral comet assay.\
(B) Cells were transfected with siRNA and treated with 4-OHT. The agarose plugs in the neutral comet assay were treated with purified APE-I for the indicated samples. All bars represent the median, and p values were derived from an ANOVA with Dunn's multiple comparisons post-test. See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1600577-f0003){#F2}

![APOBEC3A-Induced Abasic Sites Slow Replication Elongation\
(A) Three clones (c2, c9, and c11) of HCT116 GFP-APOBEC3A-ERT2 cells, or parental HCT116 cells, were incubated with 4-OHT, CldU, and IdU, as indicated, and processed for DNA combing.\
(B) The uracil-DNA glycosylase inhibitor (UGI) or an empty vector (EV) was introduced by lentiviral infection before DNA combing.\
(C) hTERT-RPE-1 cells were harvested and lysed 16 h after UGI was introduced by lentiviral infection to assess UNG inhibition.\
(D) hTERT-RPE-1 GFP-APOBEC3A-ERT2 cells were infected with EV or UGI before DNA combing. All bars represent the median, and p values were derived from an ANOVA with Dunn's multiple comparisons post-test.](nihms-1600577-f0004){#F3}

![HMCES and TLS Slow Replication Elongation in Response to Nuclear APOBEC3A\
(A) Cells were transfected with HMCES (H-1 and H-2), POLK, or a non-targeting siRNA (NT) and were incubated with 4-OHT before DNA combing.\
(B) UGI or empty vector (EV) was introduced by lentiviral infection.\
(C) Cells were transfected with HMCES or non-targeting siRNA, treated with DMSO, 4-OHT, and 10 μM JH-RE-06 for 30 min as indicated, and processed for DNA combing.\
(D) Cells were transfected with HMCES and POLK siRNA, treated with 4-OHT, and processed for DNA combing. Bars represent the median, and p values were derived from an ANOVA with Dunn's multiple comparisons post-test.](nihms-1600577-f0005){#F4}

  REAGENT or RESOURCE                                                                        SOURCE                IDENTIFIER
  ------------------------------------------------------------------------------------------ --------------------- -------------------------------------------------------------------------
  Antibodies                                                                                                       
  Rabbit polyclonal anti HMCES                                                               Sigma                 Cat\#HPA044968; RRID:AB_2679160
  Rabbit polyclonal anti APOBEC3A                                                            Sigma                 Cat\# SAB4500753; RRID:AB_10742606
  Rabbit polyclonal anti GFP                                                                 Abcam                 Cat\#ab290; RRID:AB_303395
  Mouse monoclonal anti BrdU                                                                 BD                    Cat\#347580; RRID:AB_10015219
  Rat monoclonal anti BrdU                                                                   Abcam                 Cat\#ab6326; RRID:AB_305426
  Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488   Life Technologies     Cat\# A32723; RRID:AB_2633275
  Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 594                 Life Technologies     Cat\# A11007; RRID:AB_10561522
  Chemicals, Peptides, and Recombinant Proteins                                                                    
  JHRE06                                                                                     VICB synthesis core   N/A
  CldU                                                                                       Sigma Aldrich         Cat\#C6891
  IdU                                                                                        Sigma Aldrich         Cat\#l7125
  EdU                                                                                        VICB synthesis core   N/A
  4-Hydroxytamoxifen                                                                         Tocris                Cat\#3412/10
  MG-132                                                                                     Sigma Aldrich         Cat\#M7449
  Hoescht 33342                                                                              ThermoFisher          Cat\#62249
  Alexa Fluor 488 Azide                                                                      ThermoFisher          Cat\#A10266
  APE-I                                                                                      NEB                   Cat\#M0282S
  Uracil-DNA Glycosylase (UDG)                                                               NEB                   Cat\#M0280S
  Critical Commercial Assays                                                                                       
  Duolink *In Situ* PLA Probe Anti-Rabbit PLUS                                               Sigma-Aldrich         Cat\#DU092002
  Duolink *In Situ* PLA Probe Anti-Rabbit MINUS                                              Sigma-Aldrich         Cat\#DU092004
  Duolink *In Situ* Detection Reagents, Red                                                  Sigma-Aldrich         Cat\#DU092008
  Comet Assay Kit                                                                            Trevigen              Cat\#4250--050-K
  FiberPrep Kit                                                                              Genomic Vision        Cat\#EXTR-001
  Combi Coverslips                                                                           Genomic Vision        Cat\#COV-002-RUO
  U2OS                                                                                       ATCC                  Cat\#HTB-96; RRID:CVCL_0042
  hTERT-RPE-1                                                                                ATCC                  Cat\#CRL-4000; RRID:CVCL_4388
  HCT-116                                                                                    ATCC                  Cat\#CCL-247; RRID:CVCL_0291
  Oligonucleotides                                                                                                 
  HMCES siRNA                                                                                Dharmacon             Cat\#D-020333--01
  HMCES siRNA                                                                                Dharmacon             Cat\#J-020333--19
  PolK siRNA                                                                                 Dharmacon             Cat\#D-021038--01
  PolK siRNA                                                                                 Dharmacon             Cat\#D-021038--02
  PolK siRNA                                                                                 Dharmacon             Cat\#D-021038--03
  PolK siRNA                                                                                 Dharmacon             Cat\#D-021038--04
  APEX1 siRNA                                                                                Dharmacon             Cat\#D-010237--01
  APEX1 siRNA                                                                                Dharmacon             Cat\#D-010237--02
  APEX1 siRNA                                                                                Dharmacon             Cat\#D-010237--03
  APEX1 siRNA                                                                                Dharmacon             Cat\#D-010237--05
  APEX2 siRNA                                                                                Dharmacon             Cat\#D-013730--01
  APEX2 siRNA                                                                                Dharmacon             Cat\#D-013730--02
  APEX2 siRNA                                                                                Dharmacon             Cat\#D-013730--03
  APEX2 siRNA                                                                                Dharmacon             Cat\#D-013730--05
  AllStars Negative Control siRNA                                                            QIAGEN                Cat\#1027281
  Recombinant DNA                                                                                                  
  pAcGFP-ERT2                                                                                [@R10]                Mailand Lab
  APOBEC3A cDNA                                                                              Dharmacon             Cat\# OHS5894--9916829
  pAcGFP-APOBEC3A-ERT2                                                                       This paper            N/A
  PiggyBac Transposon Vectors                                                                Systems Biosciences   Cat\# PB510B-1
  PiggyBac-GFP-APOBEC3A-ERT2                                                                 This paper            N/A
  Software and Algorithms                                                                                          
  Graphpad Prism                                                                             Graphpad Software     <https://www.graphpad.com/scientific-software/prism/>; RRID: SCR_000306
  Fiji                                                                                       [@R23]                [http://fiji.sc](http://fiji.sc/) RRID:SCR_002285
  OpenComet                                                                                  [@R9]                 N/A
  Other                                                                                                            

###### Highlights

-   HMCES-deficient cells are hypersensitive to nuclear APOBEC3A (A3A) localization

-   HMCES protects abasic sites from processing into double-strand breaks

-   A3A-induced abasic sites slow both leading and lagging strand replication

-   TLS polymerases zeta (Polζ) and kappa (Polκ) slow fork elongation in the absence of HMCES
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